Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma ...

Aptar CSP Technologies, part of AptarGroup Inc., has expanded its service offerings with the launch of a cGMP-compliant ...

PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

Matica Biotechnology, a specialized CDMO for cell and gene therapies, has partnered with the National Center for Therapeutics ...

Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock, plus one non-tradeable contingent ...

Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and ...

VERAXA Biotech AG ( VERAXA) has entered a co-discovery alliance with OmniAb, Inc. for the development of a novel bispecific antibody drug conjugate (bsADC) program targeting solid tumors.

Bristol Myers Squibb plans to close its viral vector production facility in Libertyville, IL according to a BMS spokesperson ...

SK pharmteco has opened its new Current Good Manufacturing Practice (CGMP) plasmid suite at its facility in King of Prussia, ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s IMAAVY (nipocalimab-aahu), a human FcRn-blocking ...

Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.

CND has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most recent Series A3 offering.